These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 16521635
61. Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure. Tanaka K, Kato K, Takano T, Katagiri T, Asanoi H, Nejima J, Nakashima M, Kamijo T, Sakanashi M. J Cardiol; 2010 Nov; 56(3):291-9. PubMed ID: 20709498 [Abstract] [Full Text] [Related]
62. Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension. Sandqvist A, Henrohn D, Egeröd H, Hedeland M, Wernroth L, Bondesson U, Schneede J, Wikström G. Eur J Clin Pharmacol; 2015 Oct; 71(10):1165-73. PubMed ID: 26242227 [Abstract] [Full Text] [Related]
64. Reversible pulmonary hypertension in a patient treated with protacyclin. Engel PJ, Baughman R, Johnson H, Kereikes DJ. J Invasive Cardiol; 2004 Nov; 16(11):660-2. PubMed ID: 15550741 [No Abstract] [Full Text] [Related]
65. Long-term favourable effect of nifedipine in primary pulmonary hypertension. Report of a case with hemodynamic evaluation after 3 and after 16 months and with clinical follow-up during 36 months. Musante R, Di Donato M. G Ital Cardiol; 1985 Nov; 15(11):1110-2. PubMed ID: 3830769 [Abstract] [Full Text] [Related]
66. Hemodynamic effects of oral nicorandil in congestive heart failure. Tice FD, Binkley PF, Cody RJ, Moeschberger ML, Mohrland JS, Wolf DL, Leier CV. Am J Cardiol; 1990 Jun 01; 65(20):1361-7. PubMed ID: 2140489 [Abstract] [Full Text] [Related]
67. Pulmonary hypertension during epileptic seizure with evidence of increased angiotensin II in pulmonary artery. Ueno Y, Takagi A, Kawana M, Kasanuki H. Heart Vessels; 2005 Feb 01; 20(1):37-8. PubMed ID: 15700201 [Abstract] [Full Text] [Related]
68. [Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension]. Jia WB, Jiang X, Zuo XR, He J, Zhao QH, Jiang R, Jing ZC. Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug 01; 40(8):652-6. PubMed ID: 23141008 [Abstract] [Full Text] [Related]
69. [Pressure-flow relationships interpretation in idiopathic pulmonary arterial hypertension]. Lupi-Herrera E, Santos-Martínez LE, Pulido T, Sandoval J. Arch Cardiol Mex; 2010 Aug 01; 80(3):163-73. PubMed ID: 21147582 [Abstract] [Full Text] [Related]
70. [Intensive care for severe acute pneumonia using hemodynamic pulmonary circulatory unloading]. Stoliarova NA, Sadchikova GD. Anesteziol Reanimatol; 2005 Aug 01; (4):46-9. PubMed ID: 16206586 [Abstract] [Full Text] [Related]
71. Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes. Hattori H, Minami Y, Mizuno M, Yumino D, Hoshi H, Arashi H, Nuki T, Sashida Y, Higashitani M, Serizawa N, Yamada N, Yamaguchi J, Mori F, Shiga T, Hagiwara N. Heart Vessels; 2013 May 01; 28(3):345-51. PubMed ID: 22526380 [Abstract] [Full Text] [Related]
72. Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain. Arnold JM, Kowey PR, Wolf DL, Jungbluth GL, Hearron AE, Luderer JR. Int J Cardiol; 1994 May 01; 44(3):203-15. PubMed ID: 8077066 [Abstract] [Full Text] [Related]
73. Left and right ventricular power: outputs are the strongest hemodynamic correlates to allow identification of acute responders to vasodilator treatment in idiopathic pulmonary arterial hypertension. Lupi-Herrera E, Sandoval J, Figueroa J, Carrillo A, Aguirre R, Santos-Martínez LE, Pulido T. Arch Cardiol Mex; 2011 May 01; 81(2):100-7. PubMed ID: 21775243 [Abstract] [Full Text] [Related]
74. Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation. Minami Y, Nagashima M, Kajimoto K, Shiga T, Hagiwara N. J Cardiovasc Pharmacol; 2009 Oct 01; 54(4):335-40. PubMed ID: 19687747 [Abstract] [Full Text] [Related]
75. The effect of the K+ agonist nicorandil on peripheral vascular resistance. Brodmann M, Lischnig U, Lueger A, Stark G, Pilger E. Int J Cardiol; 2006 Jul 28; 111(1):49-52. PubMed ID: 16055211 [Abstract] [Full Text] [Related]
76. [Long-term course of primary vascular pulmonary hypertension with and without intake of appetite depressants]. Voss H, Feigel H, Bücking J. Z Kardiol; 1983 Apr 28; 72(4):215-21. PubMed ID: 6868739 [Abstract] [Full Text] [Related]
77. [The effects of hypertonic NaCl (7.5%) in dogs with induced acute pulmonary artery obstruction]. Ulkü R, Eren NM, Cakir O, Satici O, Balci A, Eren S. Tuberk Toraks; 2003 Apr 28; 51(2):145-51. PubMed ID: 15143420 [Abstract] [Full Text] [Related]
78. [Primary pulmonary arterial hypertension. Effects of vasodilators apropos of a case with a pulmonary biopsy]. Lemoigne F, Bonnaud F, Clary C, Macone F, Blaive B. Rev Mal Respir; 1984 Apr 28; 1(6):337-42. PubMed ID: 6531513 [Abstract] [Full Text] [Related]
79. [Acute hemodynamic effects of intravenous administration of molsidomine in secondary pulmonary hypertension and right heart failure]. Jahed MM. Med Klin (Munich); 1994 Jul 28; 89 Suppl 2():58-61. PubMed ID: 7968906 [No Abstract] [Full Text] [Related]
80. [Effects of nicorandil on regional cerebral oxygen saturation]. Kasuya Y, Dohi S. Masui; 1997 Oct 28; 46(10):1305-9. PubMed ID: 9369043 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]